Press ReleaseMar | 7 | 2024
New Insights Into the Silencing of X Chromosome Genes Passed on From Fathers to Daughters
Key Takeaways
- Investigators have found that while some genes on the X chromosome passed from father to daughter become newly inactivated during embryo development, others are inherited from the father in a surprisingly pre-silenced state
- These pre-suppressed genes tended to be the oldest in terms of their evolutionary age on the X-chromosome
- The findings suggest a conserved mechanism whereby the paternal germline ensures that sons and daughters get the same “dose” of the X chromosome during development
BOSTON – Daughters inherit two X chromosomes (one from the mother and one from the father), while sons inherent an X chromosome only from the mother.
In new research published in Molecular Cell, investigators at Massachusetts General Hospital (MGH) discovered that a large part of the X chromosome that a father passes on to his daughter is silent, even before fertilization.
This may be a mechanism to balance X-linked gene activity between the sexes during early embryo development, as well as during evolution as the Y-chromosome (which started off equal to the X) lost more and more of its genetic material.
For the study, scientists analyzed the pattern and timing of gene expression in mouse embryos. They found that some genes on the X chromosome passed on from the father become newly inactivated during female embryo development, as previous research has shown. Others, however, were inherited from the father in a pre-suppressed state, a finding that had not been demonstrated before, although the idea was long-postulated. Interestingly, these pre-suppressed genes tended to be the oldest in terms of their evolutionary age on the X chromosome.
“We believe that this is an ancient mechanism whereby the paternal germline ensures that sons and daughters get the same ‘dose’ of the X chromosome during embryogenesis. Otherwise, daughters would always have twice as many X-genes as sons, which would put male embryos at a disadvantage,” explains senior author Jeannie T. Lee, MD, PhD, the Phillip A. Sharp Endowed Chair in Molecular Biology at MGH and a Professor of Genetics at Harvard Medical School. “
These pre-silenced genes need to be precisely controlled in embryos, and this mechanism also avoids overdosage of X-genes in daughters,” adds first author and postdoctoral fellow, Chunyao Wei, PhD.
It turns out that balancing sex chromosomes is even more complex, as the maternal X chromosome has to be turned up in expression in both male and female offspring to keep balance with the rest of the genome. Lee and her colleagues also found that hyper-activation of genes on the maternal X chromosome was timed with silencing of genes on the paternal X chromosome during female embryo development.
Therefore, when genes on the paternal X chromosome were expressed, they were moderately expressed on the maternal X chromosome, but when genes on the paternal chromosome were silenced, they were highly expressed on the maternal X chromosome. “This fine balancing act ensures that other chromosomes, which are always present in two copies, do not overpower the X chromosome,” says Lee.
Study co-authors include Barry Kesner and Hao Yin.
This work was supported by the National Institutes of Health.
About the Massachusetts General Hospital
Massachusetts General Hospital, founded in 1811, is the original and largest teaching hospital of Harvard Medical School. The Mass General Research Institute conducts the largest hospital-based research program in the nation, with annual research operations of more than $1 billion and comprises more than 9,500 researchers working across more than 30 institutes, centers and departments. MGH is a founding member of the Mass General Brigham healthcare system.
Type
Centers and Departments
Topics
Check out the Mass General Research Institute blog
Bench Press highlights the groundbreaking research and boundary-pushing scientists working to improve human health and fight disease.
Support Research at Mass General
Your gift helps fund groundbreaking research aimed at understanding, treating and preventing human disease.